Dextrose injection

Health care provider letter

DHCP Letter 1 DHCP Letter 2 DHCP Letter 3 DHCP Letter 4 DHCP Letter 5 DHCP Letter 6 DHCP Letter 7 DHCP Letter 8 DHCP Letter 9 DHCP Letter 10 DHCP Letter 11 DHCP Letter 12 DHCP Letter 13 DHCP Letter 14 DHCP Letter 15 DHCP Letter 16 DHCP Letter 17

Ingredients and appearance - Product information

Dextrose injection- Dextrose monohydrate

Product information

Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC: 0338-9533
Route of Administration Intravenous

Active Ingredient/Active Moiety

Ingredient Name Strength
Dextrose monohydrate ( UNII: LX22YL083G)( Anhydrous dextrose - UNII: 5SL0G7R0OK ) 50 mgin 50 mL

Product Characteristics

Marketing Information

Marketing Category Application Number or Monograph Citation Territorial Authority Marketing Start Date
Unapproved drug for use in drug shortage USA

Dextrose injection- Dextrose monohydrate

Product information

Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC: 0338-9530
Route of Administration Intravenous

Active Ingredient/Active Moiety

Ingredient Name Strength
Dextrose monohydrate ( UNII: LX22YL083G)( Anhydrous dextrose - UNII: 5SL0G7R0OK ) 50 mgin 100 mL

Product Characteristics

Marketing Information

Marketing Category Application Number or Monograph Citation Territorial Authority Marketing Start Date
Unapproved drug for use in drug shortage USA

Labeler - Baxter Healthcare Corporation( 005083209)

Establishment

Name ID/FEI Business Operations
Baxter Healthcare Corporation 005083209 ANALYSIS( 0338-9533, 0338-9530), MANUFACTURE( 0338-9533, 0338-9530), LABEL( 0338-9533, 0338-9530), PACK( 0338-9533, 0338-9530), STERILIZE( 0338-9533, 0338-9530)

Package/label principal display panel

JB0081
50 mL
DIN 00060348
5% Dextrose Injection USP

Bar Code
(01)00809080000999

APPROX mOsmol/L 252 pH 4.0
SINGLE DOSE / DOSAGE UNIQUE
PER/PAR mL DEXTROSE HYDROUS USP /
DEXTROSE HYDRATE USP 50 mg pH MAY
BE ADJUSTED WITH SODIUM HYDROXIDE /
IV FLUID NUTRIENT REPLENISHER / USE AS
PRESCRIBED / DIRECTION SHEET AVAILABLE
UPON REQUEST / SQUEEZE AND INSPECT
BAG / DISCARD IF LEAKING / MUST NOT BE
USED IN SERIES CONNECTIONS / DO NOT
ADMINISTER SIMULTANEOUSLY WITH BLOOD /
STORE AT 15C TO 25 C

Ph PEUT ETRE ADJUSTE AVEC DE LHYDROXYDE DE SODIUM / SO-
LUTION IV POUR NUTRITION PARENTERALE / ADMINISTRER TEL
QUE PRESCRIT PAR LE MEDECIN / FEUILLE DE MODE DEMPLOI
DISPONIBLE SUR DEMANDE / PRESSER ET INSPECTER LE SAC /
JETER EN CAS DE FUITES / NE DOIT PAS ETRE MONTE EN SERIE /
NE PAS ADMINISTRER SIMULTANEMENT AVEC LE SANG /
GARDER ENTRE 15C ET 25 C
NONPYROGENIC / STERILE / APYROGENE
VIAFLEX® PVC CONTAINER / CONTENANT DE PVC

Baxter Logo
Baxter Corporation Mississauga ON L5N 0C2

No Latex Symbol
88-70-20-274

JB0082
100 mL
DIN 00060348
5% Dextrose Injection USP

Bar Code
(01)00809080001002

APPROX mOsmol/L 252 pH 4.0
SINGLE DOSE/DOSAGE UNIQUE
PER/PAR mL DEXTROSE HYDROUS
USP /DEXTROSE HYDRATE USP 50 mg
pH MAY BE ADJUSTED WITH SODIUM
HYDROXIDE /IV FLUID NUTRIENT
REPLENISHER / USE AS PRESCRIBED /
DIRECTION SHEET AVAILABLE UPON
REQUEST / SQUEEZE AND INSPECT BAG / DISCARD IF
LEAKING / MUST NOT BE USED IN SERIES CONNEC-
TIONS / DO NOT ADMINISTER SIMULTANEOUSLY WITH
BLOOD / STORE AT 15C TO 25 C
pH PEUT ETRE AJUSTE AVEC DE LHYDROXYDE DE
SODIUM / SOLUTION IV POUR NUTRITION PARENTERALE
/ ADMINISTRER TEL QUE PRESCRIT PAR LE MEDECIN
/ FEUILLE DE MODE DEMPLOI DISPONIBLE SUR DE-
MANDE / PRESSER ET INSPECTER LE SAC / JETER EN
CAS DE FUITES / NE DOIT PAS ETRE MONTE EN SERIE /
NE PAS ADMINISTRER SIMULTANEMENT AVEC LE SANG /
GARDER ENTRE 15C ET 25 C
NONPYROGENIC / STERILE / APYROGENE
VIAFLEX® PVC CONTAINER / CONTENANT DE PVC

Baxter Logo
Baxter Corporation Mississauga ON L5N 0C2

No Latex Symbol
88-70-20-275